SPL 2.06% 9.5¢ starpharma holdings limited

[IMG] 2024 ASCO Annual Meeting 2024 ASCO Annual Meeting Oral...

  1. 12,921 Posts.
    lightbulb Created with Sketch. 1451







    2024 ASCO Annual Meeting


    2024 ASCO Annual Meeting
    Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 1 – 3:00 PM CDT
    location_onHall D1




    2024 ASCO Annual Meeting
    Rapid Oral Abstract Session

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
    June 3 – 8:00 AM CDT
    location_onS406
    Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.

    8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
-0.002(2.06%)
Mkt cap ! $39.64M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $10.25K 106.1K

Buyers (Bids)

No. Vol. Price($)
3 18324 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 159206 3
View Market Depth
Last trade - 16.10pm 14/10/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.